Skip to main content
Top
Published in: World Journal of Urology 4/2011

01-08-2011 | Topic Paper

Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy

Authors: Thomas F. Chromecki, Behfar Ehdaie, Giacomo Novara, Karl Pummer, Richard Zigeuner, Christian Seitz, Armin Pycha, Richard K. Lee, Eugene K. Cha, Pierre I. Karakiewicz, Casey Ng, Jay D. Raman, Felix K. Chun, Hans-Martin Fritsche, Kazumasa Matsumoto, Wassim Kassouf, Thomas J. Walton, Patrick J. Bastian, Juan I. Martínez-Salamanca, Douglas S. Scherr, Shahrokh F. Shariat

Published in: World Journal of Urology | Issue 4/2011

Login to get access

Abstract

Purpose

Higher chronological age has been suggested to confer worse prognosis in patients with upper tract urothelial carcinoma (UTUC). The aim of the current study was to test this hypothesis in a large multicenter external validation cohort of patients treated with radical nephroureterectomy (RNU) while controlling for patient performance status.

Materials and methods

We retrospectively reviewed the data from 1,169 patients treated with RNU for UTUC. Age at RNU was analyzed both as a continuous and categorical variable (<50 years, n = 66; 50–59.9 years, n = 185; 60–69.9 years, n = 367; 70–79.9 years, n = 419; ≥80 years, n = 132). Median follow-up was 37 months.

Results

Actuarial recurrence-free, cancer-specific, and all-cause survival estimates at 5 years after RNU were 69, 73, and 61%, respectively. Advanced age was associated with female gender, higher ECOG status, higher ASA score, and a lower probability of receiving adjuvant chemotherapy (all P values ≤ 0.02). In multivariable analyses, advanced age was associated with decreased recurrence-free (P = 0.021), cancer-specific (P = 0.002), and all-cause survival (P < 0.001) after controlling for the effects of gender, tumor location, number of lymph nodes removed, tumor grade, stage, architecture, necrosis, and lymphovascular invasion. After addition of ECOG status, age remained an independent predictor of only all-cause mortality (P > 0.001).

Conclusions

We confirmed that advanced patient age at the time of RNU is associated with worse clinical outcomes after surgery. However, ECOG performance status abrogated the association. Furthermore, a large proportion of elderly patients were cured with RNU. This suggests that chronological age alone is an inadequate indicator criterion to predict response of older UTUC patients to RNU.
Literature
1.
go back to reference Scher H et al. (1998) NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 12(7A):225–271 Scher H et al. (1998) NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 12(7A):225–271
2.
go back to reference Sun M et al (2010) Management of upper urinary tract urothelial carcinoma. Expert Rev Anticancer Ther 10(12):1955–1965PubMedCrossRef Sun M et al (2010) Management of upper urinary tract urothelial carcinoma. Expert Rev Anticancer Ther 10(12):1955–1965PubMedCrossRef
3.
go back to reference Shariat S et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105(12):1672–1677PubMedCrossRef Shariat S et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105(12):1672–1677PubMedCrossRef
4.
go back to reference Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27(6):653–667PubMedCrossRef Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27(6):653–667PubMedCrossRef
5.
go back to reference Nielsen M et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706 (discussion 706–708) Nielsen M et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706 (discussion 706–708)
6.
go back to reference Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRef Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRef
7.
go back to reference Epstein JI (1998) The World Health Organization/International society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol 22(12):1435–1448PubMedCrossRef Epstein JI (1998) The World Health Organization/International society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol 22(12):1435–1448PubMedCrossRef
8.
go back to reference Shariat SF et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105(10):1402–1412PubMedCrossRef Shariat SF et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105(10):1402–1412PubMedCrossRef
9.
go back to reference Nielsen ME et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706(discussion 706–708) Nielsen ME et al. (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3):699–706(discussion 706–708)
10.
go back to reference EM M (2008) Urothelial tumors of the bladder. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology. Saunders-Elsevier, Philadeiphia, Amsterdam, pp 2407–2446 EM M (2008) Urothelial tumors of the bladder. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology. Saunders-Elsevier, Philadeiphia, Amsterdam, pp 2407–2446
11.
go back to reference Benson RJ, Tomera K, Kelalis P (1983) Transitional cell carcinoma of the bladder in children and adolescents. J Urol 130(1):54–55PubMed Benson RJ, Tomera K, Kelalis P (1983) Transitional cell carcinoma of the bladder in children and adolescents. J Urol 130(1):54–55PubMed
12.
go back to reference Fitzpatrick J, Reda M (1986) Bladder carcinoma in patients 40 years old or less. J Urol 135(1):53–54PubMed Fitzpatrick J, Reda M (1986) Bladder carcinoma in patients 40 years old or less. J Urol 135(1):53–54PubMed
13.
go back to reference Linn J et al (1998) The molecular characteristics of bladder cancer in young patients. J Urol 159(5):1493–1496PubMedCrossRef Linn J et al (1998) The molecular characteristics of bladder cancer in young patients. J Urol 159(5):1493–1496PubMedCrossRef
14.
go back to reference Madgar I et al (1988) Long-term followup of patients less than 30 years old with transitional cell carcinoma of bladder. J Urol 139(5):933–934PubMed Madgar I et al (1988) Long-term followup of patients less than 30 years old with transitional cell carcinoma of bladder. J Urol 139(5):933–934PubMed
15.
go back to reference Witjes J, Debruyne F (1989) Bladder carcinoma in patients less than 40 years of age. Urol Int 44(2):81–83PubMedCrossRef Witjes J, Debruyne F (1989) Bladder carcinoma in patients less than 40 years of age. Urol Int 44(2):81–83PubMedCrossRef
16.
go back to reference Resorlu B et al (2009) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103(4):480–483PubMedCrossRef Resorlu B et al (2009) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103(4):480–483PubMedCrossRef
17.
go back to reference Shi B et al (2008) Relationship between patient age and superficial transitional cell carcinoma characteristics. Urology 71(6):1186–1190PubMedCrossRef Shi B et al (2008) Relationship between patient age and superficial transitional cell carcinoma characteristics. Urology 71(6):1186–1190PubMedCrossRef
18.
go back to reference Johnson D, Hillis S (1978) Carcinoma of the bladder in patients less than 40 years old. J Urol 120(2):172–173PubMed Johnson D, Hillis S (1978) Carcinoma of the bladder in patients less than 40 years old. J Urol 120(2):172–173PubMed
19.
go back to reference Kurz K, Pitts W, Vaughan EJ (1987) The natural history of patients less than 40 years old with bladder tumors. J Urol 137(3):395–397PubMed Kurz K, Pitts W, Vaughan EJ (1987) The natural history of patients less than 40 years old with bladder tumors. J Urol 137(3):395–397PubMed
20.
go back to reference Kutarski P, Padwell A (1993) Transitional cell carcinoma of the bladder in young adults. Br J Urol 72(5 Pt 2):749–755 Kutarski P, Padwell A (1993) Transitional cell carcinoma of the bladder in young adults. Br J Urol 72(5 Pt 2):749–755
21.
go back to reference Wan J, Grossman H (1989) Bladder carcinoma in patients age 40 years or younger. Cancer 64(1):178–181PubMedCrossRef Wan J, Grossman H (1989) Bladder carcinoma in patients age 40 years or younger. Cancer 64(1):178–181PubMedCrossRef
22.
go back to reference Yossepowitch O, Dalbagni G (2002) Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 168(1):61–66PubMedCrossRef Yossepowitch O, Dalbagni G (2002) Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 168(1):61–66PubMedCrossRef
23.
go back to reference Roscigno M et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181(6):2482–2489PubMedCrossRef Roscigno M et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181(6):2482–2489PubMedCrossRef
24.
go back to reference Prout GR Jr (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104(8):1638–1647PubMedCrossRef Prout GR Jr (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104(8):1638–1647PubMedCrossRef
25.
go back to reference Nielsen M et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100(5):1015–1020PubMed Nielsen M et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100(5):1015–1020PubMed
26.
go back to reference Gore J et al (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 115(5):988–996PubMedCrossRef Gore J et al (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 115(5):988–996PubMedCrossRef
27.
go back to reference Waldert M et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105(6):812–817PubMedCrossRef Waldert M et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105(6):812–817PubMedCrossRef
28.
go back to reference Sesterhenn IA et al (1992) Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol 10(1):69–78PubMed Sesterhenn IA et al (1992) Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol 10(1):69–78PubMed
29.
go back to reference Cheng L et al (2005) Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 174(6):2181–2185PubMedCrossRef Cheng L et al (2005) Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 174(6):2181–2185PubMedCrossRef
30.
go back to reference Lapham RL, Grignon D, Ro JY (1997) Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 14(2):109–122PubMed Lapham RL, Grignon D, Ro JY (1997) Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 14(2):109–122PubMed
31.
go back to reference Larsen MP et al (1990) Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and “pseudovascular” invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 3(1):83–88PubMed Larsen MP et al (1990) Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and “pseudovascular” invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 3(1):83–88PubMed
32.
go back to reference Miyata Y et al (2006) Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 176(1):348–353PubMedCrossRef Miyata Y et al (2006) Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 176(1):348–353PubMedCrossRef
33.
go back to reference Straume O, Jackson DG, Akslen LA (2003) Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9(1):250–256PubMed Straume O, Jackson DG, Akslen LA (2003) Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9(1):250–256PubMed
Metadata
Title
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy
Authors
Thomas F. Chromecki
Behfar Ehdaie
Giacomo Novara
Karl Pummer
Richard Zigeuner
Christian Seitz
Armin Pycha
Richard K. Lee
Eugene K. Cha
Pierre I. Karakiewicz
Casey Ng
Jay D. Raman
Felix K. Chun
Hans-Martin Fritsche
Kazumasa Matsumoto
Wassim Kassouf
Thomas J. Walton
Patrick J. Bastian
Juan I. Martínez-Salamanca
Douglas S. Scherr
Shahrokh F. Shariat
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
World Journal of Urology / Issue 4/2011
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-011-0677-0

Other articles of this Issue 4/2011

World Journal of Urology 4/2011 Go to the issue